Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4global Regulatory News (4GBL)

  • There is currently no data for 4GBL

Directorate Changes

22 Apr 2024 07:00

RNS Number : 3604L
4GLOBAL PLC
22 April 2024
Β 

22 April 2024

Β 

4GLOBAL PLC

Β 

("4GLOBAL" or the "Company")

Β 

Directorate Changes

Β 

4GLOBAL, a UK-based data and technology company focused on providing customers in the sport and fitness sector with business-critical insights about their customers, operations, and investments, is pleased to announce the appointment Eric Haller as an independent non-executive director of the Company.

Β 

Eric Haller served as the Global Executive Vice President and Group Head of Experian DataLabs, an operating division of Experian PLC. Based in San Diego and under his leadership, DataLabs generated over 53 new products for Experian adding approximately $200 million in annual recurring revenues for the company. Furthermore, Eric was pivotal in the development and execution of Experian's data commercialisation strategy that has elevated Experian to the global leader in their space with revenues in excess of $6.7bn.

Β 

Prior to his tenure at Experian, Eric operated within the start-up landscape, including his co-founding of a San Diego-based company specialising in identity fraud detection, later rebranded as ID Analytics, and acquired by LifeLock in 2012 for $185 million. Additionally, he held pivotal positions such as Chief Marketing Officer at HNC Software, which was acquired by FICO for $800 million in 2002, and executive roles at industry giants MasterCard and Visa.

Β 

Eric holds a Master of Science in Technology Management from Columbia University and a Bachelor of Science in Finance from San Diego State University.

Β 

Eric will be working with the board and 4GLOBAL's management team enhancing the corporate strategy and product development, particularly around data commercialisation strategies.

Β 

Further to the announcement of 23 January 2024, 4Global also announces that Alexandra Orlando has stepped down from the Group board, effective 11 April 2024, to focus on her role as Vice-President of our North American operations, Alexandra will focus on the expansion and advancement of the US team, the development of its core strategy and growing the sales opportunity pipeline.

Β 

Eloy Mazon, CEO, commented: "Firstly, we extend our heartfelt gratitude to Alexandra Orlando for her invaluable contributions to the Group Board and know that she will make a huge contribution in her executive role in the North Americas for the Group.

Β 

We are delighted to welcome Eric to the Board of 4global. Eric brings a wealth of knowledge and experience to 4GLOBAL on how to maximise the commercial value of data and the development of incredible commercially successful data products that has enabled the companies he has managed to maximise their potential and growth. The board and I look forward to working with Eric in bringing this experience and knowledge into 4GLOBAL."

Β 

Eric Haller, NED, commented: "I am delighted to be joining the 4GLOBAL board and I look forward to working with the management team to maximise the growth and commercial success of the company. I was impressed by the data asset that 4GLOBAL has developed and the insight solutions they provide their customers. The potential for growth of 4GLOBAL is significant given its data asset and I look forward to being part of that journey."

Β 

Eric Matthew Haller, aged 57, holds no current directorships or partnerships, nor has held any former directorships or partnerships within the last five years.

Β 

There is no further information to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

Β 

For further information please contact:

4GLOBAL

Eloy Mazon (CEO)

c/o IFC Advisory

Β 

Spark Advisory Partners - Nominated Adviser

Neil Baldwin

Β 

0203 368 3554

Β 

Canaccord Genuity Limited - Broker

Bobbie Hilliam

Β 

020 7523 8000

Β 

IFC Advisory

Graham Herring / Zach Cohen

Β 

0203 934 6630

Β 

Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAILMMTMTJBBFI
12
Date   Source Headline
27th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
15th Jun 202310:42 amRNSHolding(s) in Company
24th May 20237:00 amRNSPartnership agreement with Technogym UK
17th May 20237:00 amRNSStrategic partnership in North America
11th May 20237:00 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSChange of Broker
27th Apr 20237:00 amRNSTrading Update
13th Feb 20235:51 pmRNSAIM Rule 17 Notification
6th Feb 20231:58 pmRNSPCA Share Purchase / PDMR Dealing
21st Dec 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSSports Event Contract Win
31st Oct 20227:00 amRNS4GLOBAL secures £4M contract win
3rd Oct 20223:30 pmRNSDirectorate Change
15th Sep 20227:00 amRNS4GLOBAL and EuropeActive launch global datahub
8th Sep 202212:59 pmRNSResult of AGM
8th Sep 20227:00 amRNSBusiness Update
8th Aug 20228:53 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSDirector Share Purchase / PDMR Dealing
7th Jul 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
4th Jul 20227:00 amRNSNotice of results & investor presentation
24th May 20224:45 pmRNSDirector Share Purchase / PDMR Dealing
17th May 20223:54 pmRNSDirector Share Purchase / PDMR Dealing
31st Mar 20227:00 amRNSAppointment of Chief Customer Officer
17th Mar 20227:00 amRNSTrading Update and Contract Wins
3rd Feb 20227:00 amRNSFitness Industry Council of Canada Partnership
17th Jan 20227:00 amRNSLaunch of new Social Value Calculator
29th Dec 202110:26 amRNSHolding(s) in Company
21st Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSNew Contract Win
7th Dec 20217:00 amRNSAdmission to AIM and first day of dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.